(NASDAQ:FDMT), EMERYVILLE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference. […]
(Other OTC:GAMI),(OTC US:GAMI),(NYSE:KDVD), GREENWICH, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC (“Gabelli”) today announced the launch of the Keeley Dividend ETF (“KDVD”) on the NYSE. KDVD is an actively managed ETF that seeks to generate current income and capital appreciation by investing in dividend-paying small- and mid-cap companies. The fund is managed
(NYSE MKT:GRO),(Bovespa:GROP31.SA), Signed Contracts to Sell ~91% of Production, Strengthened Leadership Team, Advanced Site Preparation and Community Partnerships 2026 Focus on Construction Financing, Completing Advanced Engineering, Indigenous Impact Benefit Agreement, and Strategic Partnerships CEO Matt Simpson to outline company progress and discuss market dynamics in upcoming investor webinar on December 9, 2025, at 1:00 PM
(NASDAQ:NWTG), AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) — GeoCue announces the premiere of a new three-part edition of its award-winning reality series Down to Earth: Mapped Safe for 911. The latest episodes follow Fenstermaker, NEI, and the Lafayette Parish School System as they work with Lafayette Parish 911 to map every public and private school,
(NYSE:WHG), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. was recognized in the 2025 Best Places to Work in Money Management awards announced by Pensions & Investments today. Presented by Pensions & Investments, the global news source of money management and institutional investing, the 14th annual survey and recognition program is
Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one edited allele after 1 or 2 doses, respectively, exceeding the anticipated curative threshold Evidence in NHP that T cell directed lipid nanoparticles (LNP) produced
âˆ' First patient with facioscapulohumeral muscular dystrophy (FSHD) dosed with Restem-L umbilical lining modified progenitor cells (UMPCs) âˆ' The Phase 1/2a study will evaluate the safety and preliminary efficacy of Restem-L in patients with FSHD âˆ' Clinical study is funded by SOLVE FSHD MIAMI and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — RESTEM
(PinkSheets:ARVLF), BROOKLYN, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) — The Rosen Law Firm, P.A. announces that the United States District Court for the Eastern District of New York has approved the following announcement of a proposed class action settlement that would benefit purchasers of securities of Arrival SA and/or CIIG Merger Corp. (OTCMKTS: ARVLF): SUMMARY
(Euronext Amsterdam:ASML),(NASDAQ:ASML), ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased value 01-Dec-25 39,527 EUR915.08 EUR36,170,185 02-Dec-25 38,518 EUR939.05 EUR36,170,216 03-Dec-25 37,709 EUR959.19 EUR36,169,986 04-Dec-25 37,502 EUR964.47